Gene · 25937
Papers2,228
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,228
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Applications of CRISPR screening to lung cancer treatment. | Front Cell Dev Biol | 2023 | 38169973 | PubTator, text mining | PubMed |
| Hepatocyte-targeted siTAZ therapy lowers liver fibrosis in NASH diet-fed chimeric mice with hepatocyte-humanized livers. | Mol Ther Methods Clin Dev | 2023 | 38144682 | PubTator, text mining | PubMed |
| Metabolic changes with the occurrence of atherosclerotic plaques and the effects of statins. | Front Immunol | 2023 | 38143759 | PubTator, text mining | PubMed |
| Pleural Mesothelioma: Treatable Traits of a Heterogeneous Disease. | Cancers (Basel) | 2023 | 38136277 | PubTator, text mining | PubMed |
| Hippo Signaling Mediates TGFβ-Dependent Transcriptional Inputs in Cardiac Cushion Mesenchymal Cells to Regulate Extracellular Matrix Remodeling. | J Cardiovasc Dev Dis | 2023 | 38132651 | PubTator, text mining | PubMed |
| Pigmented Poroma of the Lower Eyelid: A Case Report and Literature Review. | Am J Case Rep | 2023 | 38115572 | PubTator, text mining | PubMed |
| Harnessing mechanobiology for kidney organoid research. | Front Cell Dev Biol | 2023 | 38077999 | PubTator, text mining | PubMed |
| Harnessing PROTAC technology to combat stress hormone receptor activation. | Nat Commun | 2023 | 38071198 | PubTator, text mining | PubMed |
| New Insights into YAP/TAZ-TEAD-Mediated Gene Regulation and Biological Processes in Cancer. | Cancers (Basel) | 2023 | 38067201 | PubTator, text mining | PubMed |
| Update on the Pathology of Pediatric Liver Tumors: A Pictorial Review. | Diagnostics (Basel) | 2023 | 38066766 | PubTator, text mining | PubMed |
| 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in a Rare Case of Epithelioid Hemangioendothelioma - A Diagnostic Challenge. | Indian J Nucl Med | 2023 | 38046956 | PubTator, text mining | PubMed |
| Oncofetal reprogramming in tumor development and progression: novel insights into cancer therapy. | MedComm (2020) | 2023 | 38045829 | PubTator, text mining | PubMed |
| Elucidating the causal association between gut microbiota and intrahepatic cholangiocarcinoma through Mendelian randomization analysis. | Front Microbiol | 2023 | 38033576 | PubTator, text mining | PubMed |
| TGF-β/SMAD canonical pathway induces the expression of transcriptional cofactor TAZ in liver cancer cells. | Heliyon | 2023 | 38027697 | PubTator, text mining | PubMed |
| miR-590-5p/Tiam1-mediated glucose metabolism promotes malignant evolution of pancreatic cancer by regulating SLC2A3 stability. | Cancer Cell Int | 2023 | 38017477 | PubTator, text mining | PubMed |
| CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors. | Sci Adv | 2023 | 38000020 | PubTator, text mining | PubMed |
| Cord blood DNA methylation signatures associated with preeclampsia are enriched for cardiovascular pathways: insights from the VDAART trial. | EBioMedicine | 2023 | 37995466 | PubTator, text mining | PubMed |
| Knockdown of SLC39A14 inhibits glioma progression by promoting erastin-induced ferroptosis SLC39A14 knockdown inhibits glioma progression. | BMC Cancer | 2023 | 37978473 | PubTator, text mining | PubMed |
| Vascular tumors of the liver: A brief review. | Ann Hepatobiliary Pancreat Surg | 2023 | 37953709 | PubTator, text mining | PubMed |
| TEAD Inhibition Overcomes YAP1/TAZ-Driven Primary and Acquired Resistance to KRASG12C Inhibitors. | Cancer Res | 2023 | 37934103 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/25937/papers?page=10